The current state of immunotherapy in colorectal cancer

  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 46 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 39%
  • Publisher: 51%

Medicine Research News News

Medicine Research,Health Research News,Health Research

Colorectal cancer (CRC) is a major health concern worldwide, characterized by high incidence and mortality rates. Despite advances in treatment, metastatic CRC (mCRC) remains particularly challenging.

The current state of immunotherapy in colorectal cancer retrieved 1 July 2024 from https://medicalxpress.com/news/2024-07-current-state-immunotherapy-colorectal-cancer.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.May 15, 2024 Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

PFDN6 protein could be a new target for colorectal cancer treatmentResearchers have identified a protein called PFDN6 that may play a role in the development and spread of colorectal cancer (CRC).
Source: NewsMedical - 🏆 19. / 71 Read more »

Potential new target for colorectal cancer treatmentResearchers have identified a protein called PFDN6 that may play a role in the development and spread of colorectal cancer (CRC). The study, published in [journal name], found that PFDN6 levels are increased in CRC patients and contribute to tumor growth.
Source: medical_xpress - 🏆 101. / 51 Read more »

Exploring the intricate signaling pathways in colorectal cancer: Implications for targeted therapiesColorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. The complexity of its pathogenesis, involving genetic mutations, dysregulated signaling pathways, and compromised immune surveillance, presents significant challenges for effective treatment.
Source: NewsMedical - 🏆 19. / 71 Read more »

Research identifies possible new pathway to treatment of colorectal cancerResearch led by Irving Coy Allen in the Virginia-Maryland College of Veterinary Medicine has unlocked a pathway to possible future treatments for colorectal cancer in humans.
Source: medical_xpress - 🏆 101. / 51 Read more »

Successful trial for new colorectal cancer treatment highlights promising immunotherapy drugsResults from a new trial indicate that immunotherapy could successfully be used to treat the most common form of colorectal cancer, also known as bowel cancer.
Source: medical_xpress - 🏆 101. / 51 Read more »

Appalachian Kentuckians continue to face higher colorectal cancer mortality ratesResearchers at the University of Kentucky have found that, for much of the past two decades, Appalachian Kentuckians have been more likely to die from colorectal cancer compared to the rest of the state and country's population.
Source: medical_xpress - 🏆 101. / 51 Read more »